Security
MASS · 908 Devices Inc.
MASSNASDAQCommon stockCurrentCIK 1555279Updated Sep 26, 2026
MASS price & chart
Loading TradingView…
NASDAQ:MASS on TradingView ↗About the company
908 Devices is revolutionizing chemical analysis with its simple handheld devices, addressing life-altering applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers in vital health, safety and defense tech applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure, and global security threats. The Company designs and manufactures innovative products that bring together the power of complementary analytical technologies, software automation, and machine learning. For more information, visit www.908devices.com.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 190,071,000Source | 159,476,000Source | 202,981,000Source | 242,587,000Source |
| Property, Plant and Equipment, NetUSD | 4,232,000Source | 3,421,000Source | 3,342,000Source | 3,083,000Source |
| GoodwillUSD | 0Source | 0Source | 10,367,000Source | 10,050,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 36,412,000Source | 45,261,000Source | 7,860,000Source | 8,488,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 70,517,000Source | 44,032,000Source | 121,041,000Source | 188,422,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 11,327,000Source | 12,627,000Source | 8,989,000Source | 10,033,000Source |
| Inventory, NetUSD | 12,990,000Source | 16,173,000Source | 14,938,000Source | 12,513,000Source |
| Assets, CurrentUSD | 144,559,000Source | 103,055,000Source | 173,790,000Source | 215,626,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 7,272,000Source | 4,655,000Source | 4,181,000Source | 4,658,000Source |
| Operating Lease, Right-of-Use AssetUSD | 4,397,000Source | 6,910,000Source | 6,233,000Source | 3,956,000Source |
| Other Assets, NoncurrentUSD | 471,000Source | 829,000Source | 1,389,000Source | 1,384,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 46,372,000Source | 44,884,000Source | 37,490,000Source | 51,988,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 36,000Source | 35,000Source | 33,000Source | 32,000Source |
| Additional Paid in CapitalUSD | 366,925,000Source | 356,216,000Source | 334,692,000Source | 323,969,000Source |
| Retained Earnings (Accumulated Deficit)USD | -223,316,000Source | -242,805,000Source | -170,599,000Source | -134,200,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 54,000Source | 1,146,000Source | 1,365,000Source | 798,000Source |
| Stockholders' Equity Attributable to ParentUSD | 143,699,000Source | 114,592,000Source | 165,491,000Source | 190,599,000Source |
| Liabilities and EquityUSD | 190,071,000Source | 159,476,000Source | 202,981,000Source | 242,587,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 34,064,000Source | 25,149,000Source | 22,549,000Source | 19,226,000Source |
| Operating Lease, Liability, CurrentUSD | 681,000Source | 1,865,000Source | 2,016,000Source | 1,468,000Source |
| Accounts Payable, CurrentUSD | 1,586,000Source | 2,063,000Source | 1,191,000Source | 1,397,000Source |
| Operating Lease, Liability, NoncurrentUSD | 3,947,000Source | 4,742,000Source | 3,929,000Source | 3,040,000Source |
| Deferred Income Tax Liabilities, NetUSD | — | 2,030,000Source | 2,441,000Source | 2,671,000Source |
| Other Liabilities, NoncurrentUSD | 30,000Source | 2,284,000Source | — | 555,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 6,838,000Source | 9,096,000Source | 8,713,000Source | 8,847,000Source |
| Deferred Tax Liabilities, NetUSD | 0Source | 2,030,000Source | 2,441,000Source | 2,671,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | — | 15,000,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 19,489,000Source | -72,206,000Source | -36,399,000Source | -33,563,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 4,465,000Source | 4,682,000Source | 2,384,000Source | 1,614,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 9,845,000Source | 11,763,000Source | 9,787,000Source | 7,207,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -220,000Source | 2,927,000Source | -680,000Source | -5,930,000Source |
| Increase (Decrease) in InventoriesUSD | 3,731,000Source | 1,664,000Source | 3,902,000Source | 5,475,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | -283,000Source | -305,000Source | -129,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -23,688,000Source | -30,247,000Source | -25,059,000Source | -20,930,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | 13,762,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 50,747,000Source | -46,321,000Source | -26,400,000Source | -15,807,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 955,000Source | 602,000Source | 2,045,000Source | 2,045,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -697,000Source | -376,000Source | -15,935,000Source | 1,179,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 26,389,000Source | -77,009,000Source | -67,381,000Source | -35,540,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 70,592,000Source | 44,203,000Source | 121,212,000Source | 188,593,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | 135,000Source |
| Income Taxes Paid, NetUSD | -66,000Source | 184,000Source | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 27,000Source | -65,000Source | 13,000Source | 18,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 9,701,000Source | 11,763,000Source | 9,787,000Source | 7,207,000Source |
| Amortization of Intangible AssetsUSD | 2,890,000Source | 2,746,000Source | 877,000Source | 343,000Source |
| DepreciationUSD | 1,300,000Source | 1,900,000Source | 1,500,000Source | 1,300,000Source |
| Gain (Loss) on Disposition of BusinessUSD | 55,940,000Source | — | — | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -133,000Source | -54,000Source | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | -192,000Source | -47,000Source |
| GoodwillUSD | 0Source | 0Source | 10,367,000Source | 10,050,000Source |
| Goodwill, Impairment LossUSD | — | 40,659,000Source | 0Source | 0Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -33,277,000Source | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | 52,766,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | -66,000Source | -282,000Source | -211,000Source | — |
| Inventory Write-downUSD | 513,000Source | 653,000Source | 663,000Source | 376,000Source |
| Net Income (Loss) Attributable to ParentUSD | 19,489,000Source | -72,206,000Source | -36,399,000Source | -33,563,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 19,489,000Source | — | — | — |
| Nonoperating Income (Expense)USD | 6,078,000Source | 4,230,000Source | 6,148,000Source | 1,819,000Source |
| Operating ExpensesUSD | 67,844,000Source | 106,574,000Source | 68,080,000Source | 61,405,000Source |
| Other Nonoperating Income (Expense)USD | -346,000Source | -264,000Source | -131,000Source | -83,000Source |
| Proceeds from Stock Options ExercisedUSD | 864,000Source | 1,146,000Source | 936,000Source | 1,553,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 56,197,000Source | 59,631,000Source | 50,229,000Source | 46,852,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 38,528,000Source | 53,636,000Source | 46,176,000Source | 43,879,000Source |
| Operating Income (Loss)USD | -39,421,000Source | -76,718,000Source | -42,758,000Source | -35,382,000Source |
| Other Nonoperating Income (Expense)USD | -346,000Source | -264,000Source | -131,000Source | -83,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -33,343,000Source | -72,488,000Source | -36,610,000Source | — |
| Income Tax Expense (Benefit)USD | -66,000Source | -282,000Source | -211,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | 19,489,000Source | -72,206,000Source | -36,399,000Source | -33,563,000Source |
| Earnings Per Share, BasicUSD per share | 0.54Source | -2.12Source | -1.13Source | -1.07Source |
| Earnings Per Share, DilutedUSD per share | 0.54Source | -2.12Source | -1.13Source | -1.07Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 35,898,542Source | 34,076,321Source | 32,239,394Source | 31,492,531Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 35,898,542Source | 34,076,321Source | 32,239,394Source | 31,492,531Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 2,890,000Source | 2,746,000Source | 877,000Source | 343,000Source |
| Current Income Tax Expense (Benefit)USD | -66,000Source | — | — | — |
| Goodwill, Impairment LossUSD | — | 40,659,000Source | 0Source | 0Source |
| Gross ProfitUSD | 28,423,000Source | 29,856,000Source | 25,322,000Source | 26,023,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -33,277,000Source | — | — | — |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | -0.93Source | — | — | — |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | -0.93Source | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | 52,766,000Source | — | — | — |
| Interest ExpenseUSD | — | — | 201,000Source | 129,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 19,489,000Source | — | — | — |
| Nonoperating Income (Expense)USD | 6,078,000Source | 4,230,000Source | 6,148,000Source | 1,819,000Source |
| Operating ExpensesUSD | 67,844,000Source | 106,574,000Source | 68,080,000Source | 61,405,000Source |
| Research and Development ExpenseUSD | 15,575,000Source | 25,495,000Source | 21,904,000Source | 17,526,000Source |
Filing attachments
mass-20260811xex99d1.htm · 8-K · 2026-08-11
EX-99.1 2 mass-20260811xex99d1.htm EX-99.1 Exhibit 99.1 908 Devices Reports Second Quarter 2026 Financial Results and Raises Low End of 2026 Revenue Outlook Revenue increased 23% compared to prior year Updated full year 2026 outlook reflects 21% to 25% year-over-year growth BURLINGTON, Mass. - August 11, 2026 - 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety, and defense tech applications,…
Read attachment ↗tm2613572d1_ex99-1.htm · 8-K · 2026-05-06
EX-99.1 3 tm2613572d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 908 Devices Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Outlook Revenue increased 14% compared to prior year, growth in both Mass Spec and FTIR Acquired NIRLAB AG, expanding narcotics identification capabilities BURLINGTON, Mass. - May 6, 2026 - 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense te…
Read attachment ↗tm2613572d1_ex99-2.htm · 8-K · 2026-05-06
EX-99.2 4 tm2613572d1_ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio Strategic acquisition adds integrated hardware and cloud subscription platform powered by NIR spectroscopy BURLINGTON, Mass. - May 6, 2026 - 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has completed the acquisition of NIRLAB AG, a privately held company based in Lausanne, Switzerland…
Read attachment ↗mass-20260303xex99d1.htm · 8-K · 2026-03-03
EX-99.1 2 mass-20260303xex99d1.htm EX-99.1 Exhibit 99.1 908 Devices Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Revenue Outlook Fourth quarter 2025 revenue increased 21% compared to prior year Achieved positive Adjusted EBITDA in the fourth quarter BURLINGTON, Mass. - March 3, 2026 - 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applicat…
Read attachment ↗mass-20260120xex99d1.htm · 8-K · 2026-01-20
EX-99.1 2 mass-20260120xex99d1.htm EX-99.1 Exhibit 99.1 908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025 Preliminary full year 2025 revenue of approximately $56 million, representing ~17% growth year-over-year Achieved positive Adjusted EBITDA goal in the fourth quarter BURLINGTON, Mass. - January 20, 2026 - 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital h…
Read attachment ↗tm2530656d1_ex99-1.htm · 8-K · 2025-11-10
EX-99.1 2 tm2530656d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook Year-to-date revenue increased 16% while Adjusted EBITDA loss improves 53% quarter over quarter BOSTON - November 10, 2025 - 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for…
Read attachment ↗